Immunology studies in non-human primate models of tuberculosis

被引:112
|
作者
Flynn, JoAnne L. [1 ]
Gideon, Hannah P. [1 ]
Mattila, Joshua T. [1 ]
Lin, PhilanaLing [2 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Sch Med, Dept Pediat, Childrens Hosp, Pittsburgh, PA 15213 USA
关键词
tuberculosis; immunology; non-human primate; macaque; granuloma; lymph node; TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; LATENT TUBERCULOSIS; IMMUNE-RESPONSE; CYNOMOLGUS MACAQUES; CD8(+) T; ANIMAL-MODELS; FACTOR-ALPHA;
D O I
10.1111/imr.12258
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Non-human primates, primarily macaques, have been used to study tuberculosis for decades. However, in the last 15years, this model has been refined substantially to allow careful investigations of the immune response and host-pathogen interactions in Mycobacterium tuberculosis infection. Low-dose challenge with fully virulent strains in cynomolgus macaques result in the full clinical spectrum seen in humans, including latent and active infection. Reagents from humans are usually cross-reactive with macaques, further facilitating the use of this model system to study tuberculosis. Finally, macaques develop the spectrum of granuloma types seen in humans, providing a unique opportunity to investigate bacterial and host factors at the local (lung and lymph node) level. Here, we review the past decade of immunology and pathology studies in macaque models of tuberculosis.
引用
收藏
页码:60 / 73
页数:14
相关论文
共 50 条
  • [21] Opportunities for Refinement of Non-Human Primate Vaccine Studies
    Prescott, Mark J.
    Clark, Carolyn
    Dowling, William E.
    Shurtleff, Amy C.
    VACCINES, 2021, 9 (03)
  • [22] Development of Lipoprotein(a) siRNAs for Mechanism of Action Studies in Non-Human Primate Models of Atherosclerosis
    Marija Tadin-Strapps
    Michael Robinson
    Lauretta Le Voci
    Lori Andrews
    Satya Yendluri
    Stephanie Williams
    Steve Bartz
    Douglas G. Johns
    Journal of Cardiovascular Translational Research, 2015, 8 : 44 - 53
  • [23] Development of Lipoprotein(a) siRNAs for Mechanism of Action Studies in Non-Human Primate Models of Atherosclerosis
    Tadin-Strapps, Marija
    Robinson, Michael
    Le Voci, Lauretta
    Andrews, Lori
    Yendluri, Satya
    Williams, Stephanie
    Bartz, Steve
    Johns, Douglas G.
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2015, 8 (01) : 44 - 53
  • [24] Preclinical PET/CT imaging in a non-human primate model of tuberculosis
    Carney, Jonathan
    Lopresti, Brian
    Laymon, Charles
    Coleman, Teresa
    Mountz, James
    Tomko, Jamie
    Frye, Lonnie
    Flynn, Joanne
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [25] Non-human primate models and systems for gait and neurophysiological analysis
    Liang, Fengyan
    Yu, Shanshan
    Pang, Siqi
    Wang, Xiao
    Jie, Jing
    Gao, Fei
    Song, Zhenhua
    Li, Binbin
    Liao, Wei-Hsin
    Yin, Ming
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [26] REFINING NON-HUMAN PRIMATE CANCER MODELS: BEHAVIORAL FACTORS
    Schapiro, Steven J.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3475 - 3475
  • [27] A comparison of fluctuating asymmetry models in non-human primate crania
    Romero, Ashly N.
    Terhune, Claire E.
    AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY, 2018, 165 : 230 - 230
  • [28] Induction of transplantation tolerance in non-human primate preclinical models
    Hale, DA
    Dhanireddy, K
    Bruno, D
    Kirk, AD
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2005, 360 (1461) : 1723 - 1737
  • [29] Non-human primate models of HIV maternal and infant immunization
    Fouda, Genevieve
    JOURNAL OF MEDICAL PRIMATOLOGY, 2018, 47 (05) : 317 - 317
  • [30] Interests of the Non-Human Primate Models for HIV Cure Research
    Terrade, Gauthier
    Huot, Nicolas
    Petitdemange, Caroline
    Lazzerini, Marie
    Orta Resendiz, Aurelio
    Jacquelin, Beatrice
    Muller-Trutwin, Michaela
    VACCINES, 2021, 9 (09)